Sentences with phrase «experimental lung cancer drug»

said they will discontinue a late - stage trial of their experimental lung cancer drug after an interim analysis showed it would not meet the main goal of improving overall survival.

Not exact matches

The international early Phase II trial led by a team based at the Oxford Cancer Research Centre will trial the experimental drug called LY2181308 with advanced non-small cell lung cancer patients who no longer respond to platinum chemotherapy - the standard initial treatment for this Cancer Research Centre will trial the experimental drug called LY2181308 with advanced non-small cell lung cancer patients who no longer respond to platinum chemotherapy - the standard initial treatment for this cancer patients who no longer respond to platinum chemotherapy - the standard initial treatment for this group.
Cancer Research UK scientists in Oxford are trialling an experimental drug to treat lung cancer patients who have stopped responding to initial chemotherapy treaCancer Research UK scientists in Oxford are trialling an experimental drug to treat lung cancer patients who have stopped responding to initial chemotherapy treacancer patients who have stopped responding to initial chemotherapy treatment.
Several other drugs that are designed to modulate the anti-cancer immune response, such as anti-PD1 and anti-GITR, are showing promise in experimental studies in melanoma and other cancers, including colorectal, kidney, lung, prostate, and ovarian cancers and sarcoma.
a b c d e f g h i j k l m n o p q r s t u v w x y z